Revenue (Annual) Chart

View Revenue (Annual) for POCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (Annual) Chart
Start Trial

Historical Revenue (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2025 19.09M
June 30, 2024 19.10M
June 30, 2023 21.04M
June 30, 2022 15.68M
June 30, 2021 10.67M
June 30, 2020 9.923M
June 30, 2019 6.804M
June 30, 2018 4.038M
June 30, 2017 3.154M
June 30, 2016 3.917M
June 30, 2015 3.912M
June 30, 2014 3.651M
June 30, 2013 2.520M
June 30, 2012 2.152M
Date Value
June 30, 2011 2.245M
June 30, 2010 3.094M
June 30, 2009 3.528M
June 30, 2008 2.902M
June 30, 2007 2.478M
June 30, 2006 2.150M
June 30, 2005 1.350M
June 30, 2004 1.465M
June 30, 2003 2.399M
June 30, 2002 1.774M
June 30, 2001 4.248M
June 30, 2000 3.010M
June 30, 1999 3.029M
June 30, 1998 4.053M

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (Annual) Range, Past 5 Years

View Revenue (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (Annual) Benchmarks

View Revenue (Annual) Benchmarks
Start Trial
RxSight, Inc. 134.48M
Abbott Laboratories 44.33B
Align Technology, Inc. 4.035B
AngioDynamics, Inc. 320.17M
Accuray, Inc. 401.95M